Vaccines

Big pharmaceutical companies often are not interested in going through extensive approval procedures or to proceed with existing approvals regarding vaccines for minor use ore minor species. Therefore custom made vaccines provide a solution if no commercial vaccines are available.

Pathogens could change over time in their antigenic characteristics. Therefore the protective efficiency of antigens in commercial vaccines possibly might decrease.

To achieve the best possible protective effect of a CMV it is important to continuously check the situation of pathogens in a flock for always being up to date with the composition of the vaccine. The production of CMVs requires an official approval of the laboratory, which is based on appropriate technical facilities and specific production procedures.

After successful isolation of pathogens, the isolates have to be further characterized (e.g. serotype, virulence factors). Selected pure isolates has to be propagated. In various steps the harvested isolates are finally processed into a vaccine.

One of those steps includes the addition of an adjuvant to stimulate the immune response of the vaccinated animal. We routinely use aluminium hydroxide for aqueous vaccines, incomplete Freund’sches adjuvans for water-in-oil-vaccines and commercial oil-in-water adjuvants.

CMVs are always inactivated, they do not contain pathogens which are able to propagate. Normally they are parenterally injected, that means application to each individual animal.

As CMVs are produced individually for each request, we needs approximately 4 – 6 weeks (bacterial vaccines) or 6 – 8 weeks (viral vaccines/combinations of viral and bacterial pathogens) from the placed order to delivery of the vaccine. During this period for each request, the bacterial and/or viral isolates are characterized, the antigen are propagated and finally the quality of the vaccine is determined. This quality control is performed in accordance to the European pharmacopoeia.

So please note the delivery periods for each order!

Big pharmaceutical companies often are not interested in going through extensive approval procedures or to proceed with existing approvals regarding vaccines for minor use ore minor species. Therefore custom made vaccines provide a solution if no commercial vaccines are available.

Pathogens could change over time in their antigenic characteristics. Therefore the protective efficiency of antigens in commercial vaccines possibly might decrease.

To achieve the best possible protective effect of a CMV it is important to continuously check the situation of pathogens in a flock for always being up to date with the composition of the vaccine. The production of CMVs requires an official approval of the laboratory, which is based on appropriate technical facilities and specific production procedures.

After successful isolation of pathogens, the isolates have to be further characterized (e.g. serotype, virulence factors). Selected pure isolates has to be propagated. In various steps the harvested isolates are finally processed into a vaccine.

One of those steps includes the addition of an adjuvant to stimulate the immune response of the vaccinated animal. We routinely use aluminium hydroxide for aqueous vaccines, incomplete Freund’sches adjuvans for water-in-oil-vaccines and commercial oil-in-water adjuvants.

CMVs are always inactivated, they do not contain pathogens which are able to propagate. Normally they are parenterally injected, that means application to each individual animal.

As CMVs are produced individually for each request, we needs approximately 4 – 6 weeks (bacterial vaccines) or 6 – 8 weeks (viral vaccines/combinations of viral and bacterial pathogens) from the placed order to delivery of the vaccine. During this period for each request, the bacterial and/or viral isolates are characterized, the antigen are propagated and finally the quality of the vaccine is determined. This quality control is performed in accordance to the European pharmacopoeia.

So please note the delivery periods for each order!

Big pharmaceutical companies often are not interested in going through extensive approval procedures or to proceed with existing approvals regarding vaccines for minor use ore minor species. Therefore custom made vaccines provide a solution if no commercial vaccines are available.

Pathogens could change over time in their antigenic characteristics. Therefore the protective efficiency of antigens in commercial vaccines possibly might decrease.

To achieve the best possible protective effect of a CMV it is important to continuously check the situation of pathogens in a flock for always being up to date with the composition of the vaccine. The production of CMVs requires an official approval of the laboratory, which is based on appropriate technical facilities and specific production procedures.

After successful isolation of pathogens, the isolates have to be further characterized (e.g. serotype, virulence factors). Selected pure isolates has to be propagated. In various steps the harvested isolates are finally processed into a vaccine.

One of those steps includes the addition of an adjuvant to stimulate the immune response of the vaccinated animal. We routinely use aluminium hydroxide for aqueous vaccines, incomplete Freund’sches adjuvans for water-in-oil-vaccines and commercial oil-in-water adjuvants.

CMVs are always inactivated, they do not contain pathogens which are able to propagate. Normally they are parenterally injected, that means application to each individual animal.

As CMVs are produced individually for each request, we needs approximately 4 – 6 weeks (bacterial vaccines) or 6 – 8 weeks (viral vaccines/combinations of viral and bacterial pathogens) from the placed order to delivery of the vaccine. During this period for each request, the bacterial and/or viral isolates are characterized, the antigen are propagated and finally the quality of the vaccine is determined. This quality control is performed in accordance to the European pharmacopoeia.

So please note the delivery periods for each order!

Big pharmaceutical companies often are not interested in going through extensive approval procedures or to proceed with existing approvals regarding vaccines for minor use ore minor species. Therefore custom made vaccines provide a solution if no commercial vaccines are available.

Pathogens could change over time in their antigenic characteristics. Therefore the protective efficiency of antigens in commercial vaccines possibly might decrease.

To achieve the best possible protective effect of a CMV it is important to continuously check the situation of pathogens in a flock for always being up to date with the composition of the vaccine. The production of CMVs requires an official approval of the laboratory, which is based on appropriate technical facilities and specific production procedures.

After successful isolation of pathogens, the isolates have to be further characterized (e.g. serotype, virulence factors). Selected pure isolates has to be propagated. In various steps the harvested isolates are finally processed into a vaccine.

One of those steps includes the addition of an adjuvant to stimulate the immune response of the vaccinated animal. We routinely use aluminium hydroxide for aqueous vaccines, incomplete Freund’sches adjuvans for water-in-oil-vaccines and commercial oil-in-water adjuvants.

CMVs are always inactivated, they do not contain pathogens which are able to propagate. Normally they are parenterally injected, that means application to each individual animal.

As CMVs are produced individually for each request, we needs approximately 4 – 6 weeks (bacterial vaccines) or 6 – 8 weeks (viral vaccines/combinations of viral and bacterial pathogens) from the placed order to delivery of the vaccine. During this period for each request, the bacterial and/or viral isolates are characterized, the antigen are propagated and finally the quality of the vaccine is determined. This quality control is performed in accordance to the European pharmacopoeia.

So please note the delivery periods for each order!

Big pharmaceutical companies often are not interested in going through extensive approval procedures or to proceed with existing approvals regarding vaccines for minor use ore minor species. Therefore custom made vaccines provide a solution if no commercial vaccines are available.

Pathogens could change over time in their antigenic characteristics. Therefore the protective efficiency of antigens in commercial vaccines possibly might decrease.

To achieve the best possible protective effect of a CMV it is important to continuously check the situation of pathogens in a flock for always being up to date with the composition of the vaccine. The production of CMVs requires an official approval of the laboratory, which is based on appropriate technical facilities and specific production procedures.

After successful isolation of pathogens, the isolates have to be further characterized (e.g. serotype, virulence factors). Selected pure isolates has to be propagated. In various steps the harvested isolates are finally processed into a vaccine.

One of those steps includes the addition of an adjuvant to stimulate the immune response of the vaccinated animal. We routinely use aluminium hydroxide for aqueous vaccines, incomplete Freund’sches adjuvans for water-in-oil-vaccines and commercial oil-in-water adjuvants.

CMVs are always inactivated, they do not contain pathogens which are able to propagate. Normally they are parenterally injected, that means application to each individual animal.

As CMVs are produced individually for each request, we needs approximately 4 – 6 weeks (bacterial vaccines) or 6 – 8 weeks (viral vaccines/combinations of viral and bacterial pathogens) from the placed order to delivery of the vaccine. During this period for each request, the bacterial and/or viral isolates are characterized, the antigen are propagated and finally the quality of the vaccine is determined. This quality control is performed in accordance to the European pharmacopoeia.

So please note the delivery periods for each order!